Immunological tolerance is the ultimate goal of transplantation immuno
biology. Current therapies involve nonspecific immunosuppression with
concomitant risks for infection, malignancy, and drug-specific side ef
fects. By inducing specific immune unresponsiveness to the graft it sh
ould be possible to maintain transplants without the need for chronic
drug administration and without the risks of nonspecific immunosuppres
sion, This review highlights recent progress in the understanding of i
mmunological tolerance, with special attention to the long-term prospe
cts for successful induction of tolerance in renal transplant patients
.